Clinical Effect of Norepinephrine Combined with Esmolol Treatment in Patients with Septic Shock and Its Impact on Prognosis

被引:0
|
作者
Song, Mengjiao [1 ]
Su, Qiang [1 ]
Zhang, Lei [2 ]
机构
[1] Dongying Peoples Hosp, Dept Dist Intens Care Med 2, Dongying, Shandong, Peoples R China
[2] Dongying Peoples Hosp, Dept Emergency Crit Care Med, Nanyi Rd 317, Dongying 257091, Shandong, Peoples R China
来源
INTERNATIONAL JOURNAL OF GENERAL MEDICINE | 2024年 / 17卷
关键词
norepinephrine; esmolol; septic shock; cardiac function; hemodynamics; myocardial injury; inflammatory factor levels; prognosis; INTERNATIONAL CONSENSUS DEFINITIONS; BETA-BLOCKERS; SEPSIS; THERAPY;
D O I
10.2147/IJGM.S477593
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective: To unveil the influence of norepinephrine (NE) combined with esmolol treatment on cardiac function, hemodynamics, inflammatory factor levels, and prognosis in patients with septic shock. Methods: Ninety-six patients with septic shock admitted to our hospital from January 2021 to June 2023 were retrospectively analyzed and divided into the control and observation groups according to the different treatment methods. The control group was treated with standard anti-infection and fluid resuscitation, followed by NE administration [with an infusion rate of 0.1-0.5 mu g/(kg-min)]. The observation group was treated with esmolol [starting pumping rate of 50 mu g/(kg-min) and adjusting the pumping rate according to the target heart rate] in combination with the control group. Changes in hemodynamic parameters, including heart rate, mean arterial pressure, central venous pressure, cardiac index, stroke volume index, and systemic vascular resistance index, were monitored by pulse-indicating continuous cardiac output monitors before treatment (T0), 24h after treatment (T1), and 72h after treatment (T2); changes in cardiac function before and after 72h of treatment, indicators of inflammatory factors before and after treatment, and indicators of oxygenation metabolism were assessed; and adverse drug reactions during treatment were recorded in both groups. Results: NE combined with esmolol treatment improved the efficacy of patients with septic shock; was beneficial for the enhancement of blood perfusion in patients; improved the patient's cardiac function, reduced myocardial injury, and suppressed the inflammatory response in patients; improved the oxygenation metabolism and the prognosis of patients; did not significantly increase the adverse drug reactions of patients and had a better safety profile. Conclusion: NE combined with esmolol treatment can improve the efficacy of patients with septic shock, improve their cardiac function and hemodynamic indices, reduce myocardial injury and inflammatory response, and have a better safety profile, which is conducive to improving patient prognosis and reducing mortality.
引用
收藏
页码:4325 / 4333
页数:9
相关论文
共 50 条
  • [31] Renal effect of dopamine, norepinephrine, epinephrine, or norepinephrine–dobutamine in septic shock
    HB Qiu
    Y Yang
    SX Zhou
    YZ Huang
    RQ Zheng
    Critical Care, 6 (Suppl 1):
  • [32] Vasopressin Versus Norepinephrine for the Management of Septic Shock in Cancer Patients: The VANCS II Randomized Clinical Trial*
    Hajjar, Ludhmila Abrahao
    Zambolim, Cristiane
    Belletti, Alessandro
    de Almeida, Juliano Pinheiro
    Gordon, Anthony C.
    Oliveira, Gisele
    Park, Clarice Hyesuk Lee
    Fukushima, Julia Tizue
    Rizk, Stephanie Itala
    Szeles, Tais Felix
    dos Santos Neto, Nestor Cordeiro
    Kalil Filho, Roberto
    Galas, Filomena Regina Barbosa Gomes
    Landoni, Giovanni
    CRITICAL CARE MEDICINE, 2019, 47 (12) : 1743 - 1750
  • [33] Impact of methylene blue in addition to norepinephrine on the intestinal microcirculation in experimental septic shock
    Nantais, Jordan
    Dumbarton, Tristan C.
    Farah, Nizam
    Maxan, Alexander
    Zhou, Juan
    Minor, Samuel
    Lehmann, Christian
    CLINICAL HEMORHEOLOGY AND MICROCIRCULATION, 2014, 58 (01) : 97 - 105
  • [34] Effect of Early Vasopressin vs Norepinephrine on Kidney Failure in Patients With Septic Shock The VANISH Randomized Clinical Trial
    Gordon, Anthony C.
    Mason, Alexina J.
    Thirunavukkarasu, Neeraja
    Perkins, Gavin D.
    Cecconi, Maurizio
    Cepkova, Magda
    Pogson, David G.
    Aya, Hollmann D.
    Anjum, Aisha
    Frazier, Gregory J.
    Santhakumaran, Shalini
    Ashby, Deborah
    Brett, Stephen J.
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2016, 316 (05): : 509 - 518
  • [35] Effect of norepinephrine on cardiac output and preload in septic shock patients
    O Hamzaoui
    H Ksouri
    C Richard
    J Teboul
    Critical Care, 11 (Suppl 2):
  • [36] Renal autoregulation in experimental septic shock and its response to vasopressin and norepinephrine administration
    Post, Emiel Hendrik
    Su, Fuhong
    Shinotsuka, Claudia Righy
    Taccone, Fabio Silvio
    Creteur, Jacques
    De Backer, Daniel
    Vincent, Jean-Louis
    JOURNAL OF APPLIED PHYSIOLOGY, 2018, 125 (06) : 1661 - 1669
  • [37] Norepinephrine kinetics and dynamics in septic shock and trauma patients
    Beloeil, H
    Mazoit, JX
    Benhamou, D
    Duranteau, J
    BRITISH JOURNAL OF ANAESTHESIA, 2005, 95 (06) : 782 - 788
  • [38] Clinical trials comparing norepinephrine with vasopressin in patients with septic shock: a meta-analysis
    Zhou, Fei-Hu
    Song, Qing
    MILITARY MEDICAL RESEARCH, 2014, 1
  • [39] Clinical trials comparing norepinephrine with vasopressin in patients with septic shock: a meta-analysis
    Fei-Hu Zhou
    Qing Song
    Military Medical Research, 1 (1)
  • [40] Clinical trials comparing norepinephrine with vasopressin in patients with septic shock:A meta-analysis
    Fei-Hu Zhou
    Qing Song
    Military Medical Research, 2014, (01) : 44 - 50